Posted on Thursday 21st October 2010
The Binding Site, a biomedical development company started by three Medical School researchers, has won the 2010 Queen’s Award for Enterprise in the International Trade category.
The win, for its achievement in increasing export revenues to more than £42 million a year and selling more than 90% of its production overseas, marks the third time it has claimed one of the national accolades since its beginnings in 1983.
Set up in 1983 by husband and wife Professor Jo Bradwell (MBChB Medicine, 1968) and Dr Barbara Scott (BSc Biological Sciences, 1977; PhD Medicine, 1981) along with their Medical School colleague Roger Drew, The Binding Site has become a multi-million pound business employing almost 500 people around the world.
The company’s exceptional growth is largely driven by sales of ‘Freelite’, a unique tumour marker for several bone marrow cell cancers, for which the Binding Site won the Queen’s Award for Innovation in 2007.
Professor Bradwell chairs the company and maintains strong research links with the University’s Medical School. He says: ‘The prestige of the award made everyone feel extremely good about the work they’re doing here. It’s been a huge motivator for us.'
To find out more, visit www.bindingsite.com